Issue navigation
Volume 75, Issue 12, December 2020
Viewpoint
Implications of antibiotics use during the COVID-19 pandemic: present and future
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3413–3416, https://doi.org/10.1093/jac/dkaa350
Review
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3417–3424, https://doi.org/10.1093/jac/dkaa340
For debate
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3425–3432, https://doi.org/10.1093/jac/dkaa329
Systematic reviews
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3433–3457, https://doi.org/10.1093/jac/dkaa328
Influences on antibiotic prescribing by non-medical prescribers for respiratory tract infections: a systematic review using the theoretical domains framework
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3458–3470, https://doi.org/10.1093/jac/dkaa335
Original research
Emergence of livestock-associated MRSA ST398 from bulk tank milk, China
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3471–3474, https://doi.org/10.1093/jac/dkaa367
Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3475–3479, https://doi.org/10.1093/jac/dkaa374
Emergence of tigecycline- and eravacycline-resistant Tet(X4)-producing Enterobacteriaceae in the gut microbiota of healthy Singaporeans
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3480–3484, https://doi.org/10.1093/jac/dkaa372
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3485–3490, https://doi.org/10.1093/jac/dkaa360
ResFinder 4.0 for predictions of phenotypes from genotypes
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3491–3500, https://doi.org/10.1093/jac/dkaa345
Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3501–3509, https://doi.org/10.1093/jac/dkaa357
Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3510–3516, https://doi.org/10.1093/jac/dkaa352
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3517–3524, https://doi.org/10.1093/jac/dkaa349
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3525–3533, https://doi.org/10.1093/jac/dkaa355
Molecular dynamics simulations informed by membrane lipidomics reveal the structure–interaction relationship of polymyxins with the lipid A-based outer membrane of Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3534–3543, https://doi.org/10.1093/jac/dkaa376
AmpR of Stenotrophomonas maltophilia is involved in stenobactin synthesis and enhanced β-lactam resistance in an iron-depleted condition
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3544–3551, https://doi.org/10.1093/jac/dkaa358
In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3552–3562, https://doi.org/10.1093/jac/dkaa370
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3563–3567, https://doi.org/10.1093/jac/dkaa353
Aspirin, sodium benzoate and sodium salicylate reverse resistance to colistin in Enterobacteriaceae and Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3568–3575, https://doi.org/10.1093/jac/dkaa371
Octenidine/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3576–3581, https://doi.org/10.1093/jac/dkaa346
In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3582–3585, https://doi.org/10.1093/jac/dkaa351
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3586–3592, https://doi.org/10.1093/jac/dkaa354
Dimercaptosuccinic acid in combination with carbapenems against isogenic strains of Escherichia coli producing or not producing a metallo-β-lactamase in vitro and in murine peritonitis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3593–3600, https://doi.org/10.1093/jac/dkaa347
In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3601–3610, https://doi.org/10.1093/jac/dkaa373
Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3611–3618, https://doi.org/10.1093/jac/dkaa368
Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3619–3624, https://doi.org/10.1093/jac/dkaa362
β-Lactam antimicrobial pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3625–3634, https://doi.org/10.1093/jac/dkaa363
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3635–3643, https://doi.org/10.1093/jac/dkaa364
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3644–3651, https://doi.org/10.1093/jac/dkaa359
Temocillin dosage adjustment in a preterm infant with severe renal disease: a case report
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3652–3655, https://doi.org/10.1093/jac/dkaa356
Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3656–3664, https://doi.org/10.1093/jac/dkaa361
De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3665–3674, https://doi.org/10.1093/jac/dkaa375
Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3675–3681, https://doi.org/10.1093/jac/dkaa365
Experience using intravenous posaconazole in paediatric and young adult oncology patients
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3682–3687, https://doi.org/10.1093/jac/dkaa377
Management of posaconazole-induced pseudohyperaldosteronism
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3688–3693, https://doi.org/10.1093/jac/dkaa366
Research letter
A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3694–3695, https://doi.org/10.1093/jac/dkaa379
Letters to the Editor
Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3696–3697, https://doi.org/10.1093/jac/dkaa348
Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3697–3698, https://doi.org/10.1093/jac/dkaa369
Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3698–3699, https://doi.org/10.1093/jac/dkaa120
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3699–3700, https://doi.org/10.1093/jac/dkaa341
Acknowledgement of referees
Acknowledgement of Referees
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3701–3709, https://doi.org/10.1093/jac/dkaa451
